Since epithelial cell adhesion molecule (EpCAM) is overexpressed in various tumors as well as tissues such as the pancreas, CAR-T therapy targeting EpCAM theoretically may induce pancreatitis, requiring particular vigilance (86). The gene discussed is EPCAM; the disease is pancreatitis.